WB
EW icon

West Bancorporation’s Edwards Lifesciences EW Stock Holding History

West Bancorporation’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,331
Closed -$392K – 298
2022
Q1 		$392K Sell
3,331
-16
-0.5% -$1.79K 0.24% 66
2021
Q4 		$434K Buy
+3,347
New +$390K 0.34% 47
2020
Q3 		$354K Buy
+4,430
New +$346K 0.41% 46

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

West Bancorporation's EW Position: Q2 2022 in Review

West Bancorporation sold out of Edwards Lifesciences (EW) in Q2 2022, closing a stake of 3,331 shares — an estimated $392K sold.

West Bancorporation first reported a position in EW in Q3 2020 and held it in 3 quarters. The position peaked at $434K in Q4 2021. 1,272 funds tracked by Wall St. Rank hold EW as of Q2 2022.

  • West Bancorporation reported no remaining Edwards Lifesciences position as of Q2 2022 after selling out during the quarter.
  • West Bancorporation sold 3,331 Edwards Lifesciences shares in Q2 2022, an estimated $392K.
  • West Bancorporation first reported a position in Edwards Lifesciences in Q3 2020 and held it in 3 quarters.
  • West Bancorporation's Edwards Lifesciences position peaked at $434K in Q4 2021.
  • 1,272 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2022.

Based on West Bancorporation's 13F filing for Q2 2022, filed 15 Jul 2022.